Previous Close | 5.10 |
Open | 5.14 |
Bid | 5.31 x 700 |
Ask | 5.38 x 700 |
Day's Range | 5.07 - 5.35 |
52 Week Range | 4.03 - 8.96 |
Volume | |
Avg. Volume | 3,439,522 |
Market Cap | 1.102B |
Beta (5Y Monthly) | 1.96 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX ) defied analyst predictions to release its first-quarter results, which...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript May 6, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23. BCRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]
BioCryst Pharmaceuticals ( NASDAQ:BCRX ) First Quarter 2024 Results Key Financial Results Revenue: US$92.8m (up 35...